PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,529,000 | +1071.3% | 649,786 | +1199.6% | 0.42% | +1043.2% |
| Q4 2021 | $1,155,000 | -22.5% | 50,000 | 0.0% | 0.04% | -28.8% |
| Q3 2021 | $1,490,000 | -12.8% | 50,000 | 0.0% | 0.05% | -18.8% |
| Q2 2021 | $1,708,000 | +3.8% | 50,000 | 0.0% | 0.06% | -12.3% |
| Q1 2021 | $1,645,000 | -46.5% | 50,000 | 0.0% | 0.07% | -55.8% |
| Q4 2020 | $3,076,000 | +73.3% | 50,000 | 0.0% | 0.16% | +29.9% |
| Q3 2020 | $1,775,000 | – | 50,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |